Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection

BACKGROUND/AIMS: Bismuth-containing quadruple and moxifloxacin-based triple regimens are recommended as second-line therapy for Helicobacter pylori infection. The aim of this study was to compare the efficacy of each regimen. METHODS: From August 2004 to October 2012, a total of 949 patients (mean a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seong tae, Lee, Dong Ho, Lim, Ji Hyun, Kim, Nayoung, Park, Young Soo, Shin, Cheol Min, Jo, Hyun Jin, Song, In sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Gut and Liver 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477991/
https://www.ncbi.nlm.nih.gov/pubmed/25071068
http://dx.doi.org/10.5009/gnl14020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477991/
https://www.ncbi.nlm.nih.gov/pubmed/25071068
http://dx.doi.org/10.5009/gnl14020

Ejemplares similares